388 related articles for article (PubMed ID: 26924115)
1. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
[TBL] [Abstract][Full Text] [Related]
2. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
3. Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection.
Carroll KT; Bryant AK; Hirshman B; Alattar AA; Joshi R; Gabel B; Carter BS; Harismendy O; Vaida F; Chen CC
World Neurosurg; 2018 Mar; 111():e790-e798. PubMed ID: 29309983
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
[TBL] [Abstract][Full Text] [Related]
5. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC
J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904
[TBL] [Abstract][Full Text] [Related]
6. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
7. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
Kim YJ; Lee DJ; Park CK; Kim IA
Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
[TBL] [Abstract][Full Text] [Related]
8. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
Alattar AA; Carroll KT; Bryant AK; Hirshman B; Joshi R; Carter BS; Harismendy O; Chen CC
World Neurosurg; 2019 Jan; 121():e411-e418. PubMed ID: 30266697
[TBL] [Abstract][Full Text] [Related]
11. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
Zinn PO; Colen RR; Kasper EM; Burkhardt JK
Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
[TBL] [Abstract][Full Text] [Related]
12. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
[TBL] [Abstract][Full Text] [Related]
14. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
15. Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
Lai DM; Lin SM; Tu YK; Kao MC; Hung CC
J Formos Med Assoc; 1993 Mar; 92(3):220-6. PubMed ID: 8102273
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors of anaplastic gliomas.
Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
[TBL] [Abstract][Full Text] [Related]
19. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
Jiang H; Cui Y; Liu X; Ren X; Lin S
Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
[TBL] [Abstract][Full Text] [Related]
20. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]